NCT04770311

Brief Summary

The purpose of this study is to measure the effectiveness of a microbiome diet using direct food provision on dietary quality and microbiome composition among children with obesity. This study proposes a pilot randomized, controlled clinical trial in children of a dietary intervention informed by microbiome science.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 25, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

April 9, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2021

Completed
Last Updated

April 15, 2022

Status Verified

April 1, 2022

Enrollment Period

8 months

First QC Date

February 23, 2021

Last Update Submit

April 8, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in child dietary quality as measured by the DSQ

    The investigators will use the DSQ, which is the 26-item Dietary Screener Questionnaire, that asks about the frequency of consumption in the past month of selected foods and drinks. The DSQ captures intakes of fruits and vegetables, dairy/calcium, added sugars, whole grains/fiber, red meat, and processed meat. The study team will be focusing on microbiome friendly food, such as whole grains a fiber rich foods.

    Baseline, week 4 and week 8

Study Arms (2)

Control

NO INTERVENTION

In a typical Healthy Lifestyless Nutrition visit, dietitians provide medical nutrition therapy to patients and their families. This includes addressing abnormal, nutrition-related lab values and providing targeted nutrition advice (foods to include, foods to limit) in order to resolve said labs. Motivational interviewing techniques will be used to help families identify barriers to Lifestyles change and provide strategies to help overcome these barriers. Families will receive compensation per each nutritional visit.

Intervention

OTHER

Besides the usual standard of care during the nutrition visits, participants will have guidance on a microbiome-friendly diet and will receive groceries 1 time per week for 4 weeks.

Behavioral: Microbiome friendly diet

Interventions

Families in the intervention group will have a microbiome-friendly nutrition assessment and will also receive groceries one time per week for four weeks to help achieve a more microbiome-friendly diet.

Intervention

Eligibility Criteria

Age6 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Child aged 6 - 11 years (not yet aged 12)
  • Child with BMI ≥ 95th percentile
  • Parents are willing to accept home deliveries and have the ability to be home at the time and day that is most convenient for them to receive the groceries; or, have transportation available to go and pick up groceries at a time and date that is most convenient for them at a Walmart location.

You may not qualify if:

  • Does the child have a current diagnosis of obesity due to an underlying condition such as hypothyroidism, Cushing's disease, or known genetic condition?
  • Is the child currently taking any weight-loss medication (steroids, anti-psychotics, anti-depressants)
  • Has the child started a stimulant medication in the past 3 months? (stimulants include, among others, Ritalin, Adderall, concerta, focalin, vyvanse).
  • Is the child currently taking, or has taken in the past 4 weeks, an antibiotic?
  • Is the child currently taking, or plans to take in the next 4 weeks, a weight loss medication?
  • Is the patient on a pharmacotherapy or weight loss surgery track in Healthy Lifestyless?
  • Has the patient lost more than 5% of their body weight in the preceding 6 months?

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke Healthy Lifestyles Roxboro Street

Durham, North Carolina, 27704, United States

Location

MeSH Terms

Conditions

Pediatric Obesity

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Sarah Armstrong, MD

    Duke department of Pediatrics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2021

First Posted

February 25, 2021

Study Start

April 9, 2021

Primary Completion

November 20, 2021

Study Completion

November 20, 2021

Last Updated

April 15, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations